Skip to main content
Top
Published in: Clinical Rheumatology 9/2007

01-09-2007 | Original Article

Surgical outcomes and risk factors for postoperative complications in patients with Behcet’s disease

Authors: Min-Chan Park, Bum-Kee Hong, Hyuck Moon Kwon, You-Sun Hong

Published in: Clinical Rheumatology | Issue 9/2007

Login to get access

Abstract

This study aims to investigate surgical outcomes in patients with Behcet’s disease (BD) and to identify risk factors for the occurrence of postoperative complications. The medical records of 37 patients with newly diagnosed BD were reviewed retrospectively. All patients fulfilled the International Study Group criteria for diagnosis of BD and underwent surgeries after diagnosis. Demographic, clinical, and laboratory data at the time when surgeries were performed were collected and surgical modalities, postoperative complications, and postoperative medical treatments were evaluated. Forty-three surgeries were performed in 37 patients. During mean follow-up duration of 78.2 ± 50.3 months, 14 surgeries (32.6%) were complicated by wound dehiscence, infection, and graft occlusion or failure with the mean lag time of 6.0 ± 4.6 months from surgeries. Cumulative incidence of postoperative complications was 7.7% at 3 months, 25.6% at 6 months, 33.3% at 12 months, and 35.9% at 18 months. Postoperative complications occurred more frequently after surgeries that were performed in patients with positive pathergy test (P < 0.001) and after vascular surgeries than after nonvascular surgeries (P < 0.05). Moreover, surgeries that were followed by glucocorticoids with immunosuppressive agents showed a significantly lower postoperative complication rate compared to those that were followed by glucocorticoids alone and those that were not followed by medical treatment (P < 0.05). Multivariate analysis showed that a positive pathergic reaction (P < 0.05, hazard ratio = 1.91) at the time of surgery and surgeries that were not followed by treatment with glucocorticoids and immunosuppressive agent (P < 0.01, hazard ratio = 2.11) was an independent risk factor for the occurrence of postoperative complications. Our findings suggest that the occurrence of postoperative complications can be reduced when postsurgical immunosuppressive treatment was implemented and that the pathergy test can be used as screening methods for occurrence of postoperative complications in patients with BD.
Literature
1.
go back to reference Sakane T, Takeno M, Suzuki N, Inaba G (1999) Current concepts: Behcet’s disease. N Engl J Med 341:1284–1291PubMedCrossRef Sakane T, Takeno M, Suzuki N, Inaba G (1999) Current concepts: Behcet’s disease. N Engl J Med 341:1284–1291PubMedCrossRef
3.
go back to reference Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82:60–76PubMedCrossRef Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82:60–76PubMedCrossRef
4.
go back to reference O’Duffy JD (1990) Vasculitis in Behcet’s disease. Rheum Dis Clin North Am 16:423–431PubMed O’Duffy JD (1990) Vasculitis in Behcet’s disease. Rheum Dis Clin North Am 16:423–431PubMed
5.
go back to reference Duzgun N, Ates A, Aydintug OT, Demir O, Olmez U (2006) Characteristics of vascular involvement in Behcet’s disease. Scand J Rheumatol 35:65–68PubMedCrossRef Duzgun N, Ates A, Aydintug OT, Demir O, Olmez U (2006) Characteristics of vascular involvement in Behcet’s disease. Scand J Rheumatol 35:65–68PubMedCrossRef
6.
go back to reference Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C (2005) Behcet’s disease and cardiovascular involvement. Lupus 14:723–726PubMedCrossRef Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C (2005) Behcet’s disease and cardiovascular involvement. Lupus 14:723–726PubMedCrossRef
7.
go back to reference Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behcet’s syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMed Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behcet’s syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMed
8.
go back to reference Jorizzo JL, Solomon AR, Cavallo T (1985) Behcet’s syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747–751PubMed Jorizzo JL, Solomon AR, Cavallo T (1985) Behcet’s syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747–751PubMed
9.
go back to reference Ehrlich GE (1997) Vasculitis in Behcet’s disease. Int Rev Immunol 14:81–88PubMed Ehrlich GE (1997) Vasculitis in Behcet’s disease. Int Rev Immunol 14:81–88PubMed
11.
go back to reference Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behcet’s disease. Br J Surg 81:1712–1721PubMedCrossRef Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behcet’s disease. Br J Surg 81:1712–1721PubMedCrossRef
12.
go back to reference Ozeren M, Mavioglu I, Dogan OV, Yucel E (2000) Reoperation results of arterial involvement in Behcet’s disease. Eur J Vasc Endovasc Surg 20:512–516PubMedCrossRef Ozeren M, Mavioglu I, Dogan OV, Yucel E (2000) Reoperation results of arterial involvement in Behcet’s disease. Eur J Vasc Endovasc Surg 20:512–516PubMedCrossRef
13.
go back to reference Iscan ZH, Vural KM, Bayazit M (2005) Compelling nature of arterial manifestations in Behcet disease. J Vasc Surg 41:53–58PubMedCrossRef Iscan ZH, Vural KM, Bayazit M (2005) Compelling nature of arterial manifestations in Behcet disease. J Vasc Surg 41:53–58PubMedCrossRef
14.
go back to reference Hosaka A, Miyata T, Shigematsu H, Shigematsu K, Okamoto H, Ishii S et al (2005) Long-term outcome after surgical treatment of arterial lesions in Behcet disease. J Vasc Surg 42:116–121PubMedCrossRef Hosaka A, Miyata T, Shigematsu H, Shigematsu K, Okamoto H, Ishii S et al (2005) Long-term outcome after surgical treatment of arterial lesions in Behcet disease. J Vasc Surg 42:116–121PubMedCrossRef
15.
go back to reference International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
16.
go back to reference Ando M, Kosakai Y, Okita Y, Nakano K, Kitamura S (1999) Surgical treatment of Behcet’s disease involving aortic regurgitation. Ann Thorac Surg 68:2136–2140PubMedCrossRef Ando M, Kosakai Y, Okita Y, Nakano K, Kitamura S (1999) Surgical treatment of Behcet’s disease involving aortic regurgitation. Ann Thorac Surg 68:2136–2140PubMedCrossRef
17.
go back to reference Tuzun H, Besirli K, Sayin A, Vural FS, Hamuryudan V, Hizli N et al (1997) Management of aneurysms in Behcet’s syndrome: an analysis of 24 patients. Surgery 121:150–156PubMedCrossRef Tuzun H, Besirli K, Sayin A, Vural FS, Hamuryudan V, Hizli N et al (1997) Management of aneurysms in Behcet’s syndrome: an analysis of 24 patients. Surgery 121:150–156PubMedCrossRef
18.
go back to reference Le Thi Huong D, Wechsler B, Papo T, Piette JC, Bletry O, Vitoux JM et al (1995) Arterial lesions in Behcet’s disease. A study in 25 patients. J Rheumatol 22:2103–2113PubMed Le Thi Huong D, Wechsler B, Papo T, Piette JC, Bletry O, Vitoux JM et al (1995) Arterial lesions in Behcet’s disease. A study in 25 patients. J Rheumatol 22:2103–2113PubMed
19.
go back to reference Kwon Koo B, Shim WH, Yoon YS, Kwon Lee B, Choi D, Jang Y et al (2003) Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behcet’s disease. J Endovascular Ther 10:75–80CrossRef Kwon Koo B, Shim WH, Yoon YS, Kwon Lee B, Choi D, Jang Y et al (2003) Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behcet’s disease. J Endovascular Ther 10:75–80CrossRef
20.
go back to reference Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet’s disease. J Am Acad Dermatol 24:973–978PubMedCrossRef Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet’s disease. J Am Acad Dermatol 24:973–978PubMedCrossRef
21.
go back to reference Davatchi F, Shahram F, Chams H, Akbarian N, Nadji A, Gharibdoost C et al (1998) Methotrexate for ocular lesions of Behcet’s disease. Cohort study on 262 patients. Arthritis Rheum 41(suppl):S356 Davatchi F, Shahram F, Chams H, Akbarian N, Nadji A, Gharibdoost C et al (1998) Methotrexate for ocular lesions of Behcet’s disease. Cohort study on 262 patients. Arthritis Rheum 41(suppl):S356
22.
go back to reference Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behcet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16:790–795PubMedCrossRef Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behcet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16:790–795PubMedCrossRef
Metadata
Title
Surgical outcomes and risk factors for postoperative complications in patients with Behcet’s disease
Authors
Min-Chan Park
Bum-Kee Hong
Hyuck Moon Kwon
You-Sun Hong
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0530-9

Other articles of this Issue 9/2007

Clinical Rheumatology 9/2007 Go to the issue

Editorial Update

Editorial update